background
envelop
glycoprotein
lymphocyt
choriomening
viru
lcmv
effici
pseudotyp
lentivir
vector
strain
lcmv
exploit
high
affin
interact
bind
cell
surfac
subsequ
fuse
low
ph
endosom
lcmv
strain
low
affin
util
unknown
receptor
display
uniqu
tissu
tropism
pseudotyp
nonprim
felin
immunodefici
viru
fiv
vector
use
lcmv
deriv
glycoprotein
high
low
affin
evalu
properti
vitro
vivo
method
pseudotyp
fiv
lcmv
strain
envelop
glycoprotein
also
engin
point
mutat
envelop
glycoprotein
diminish
affin
direct
bind
altern
receptor
hypothes
chang
would
alter
vivo
tissu
tropism
enhanc
gene
transfer
neonat
anim
result
mice
hepat
express
greatest
late
gestat
neonat
time
point
display
surfac
fiv
lentiviru
mutant
glycoprotein
bound
weakli
immobil
addit
lcmv
pseudotyp
fiv
vector
transduct
neutral
preincub
solubl
mutant
glycoprotein
pseudotyp
vector
vivo
gene
transfer
adult
mice
either
envelop
yield
low
transduct
effici
hepatocyt
follow
intraven
deliveri
mark
contrast
neonat
gene
transfer
lcmv
envelop
notabl
vector
confer
abund
liver
lower
level
cardiomyocyt
transduct
detect
luciferas
assay
bioluminesc
imag
stain
conclus
result
suggest
development
regul
receptor
lcmv
express
abundantli
neonat
mice
lcmv
pseudotyp
vector
may
applic
neonat
gene
transfer
abbrevi
armstrong
baculoviru
autographa
californica
chargecoupl
devic
ccd
dystroglycan
dg
felin
immunodefici
viru
fiv
glycoprotein
precursor
gpc
firefli
luciferas
luc
lymphocyt
choriomening
viru
lcmv
nuclear
target
ntlacz
optic
densiti
od
pb
wv
pbst
rel
light
unit
rlu
rou
sarcoma
viru
rsv
transduc
unit
per
millilit
tu
ml
vesicular
stomat
viru
vsvg
wheat
germ
agglutinin
wga
reduct
bind
c
arenavirus
famili
singlestrand
envelop
biseg
rna
virus
includ
old
world
arenavirus
lymphocyt
choriomening
viru
lcmv
lassa
fever
viru
new
world
arenavirus
machupo
junin
guanarito
lcmv
glycoprotein
pseudotyp
retrovir
hivbas
lentivir
vector
facilit
studi
viru
biolog
gene
transfer
encod
small
rna
fragment
arenaviru
glycoprotein
precursor
gpc
posttransl
cleav
yield
believ
respons
receptor
bind
follow
phdepend
fusion
step
mediat
sever
old
world
arenavirus
util
viral
receptor
lcmv
prototyp
old
world
arenaviru
differ
strain
display
either
high
low
affin
alphadg
express
development
regul
display
highest
express
level
develop
tissu
involv
basement
membran
assembl
express
rise
embryon
stage
peak
newborn
diminish
adult
tissu
develop
investig
use
lcmv
envelop
glycoprotein
high
low
affin
lentivir
gene
transfer
applic
ubiquit
express
versatil
evolutionarili
conserv
cell
surfac
receptor
link
extracellular
matrix
cytoskeleton
make
ideal
target
pathogen
bind
dystroglycan
complex
transcrib
precursor
peptid
undergo
posttransl
cleavag
produc
noncoval
link
act
peripher
transmembran
protein
respect
interestingli
usag
correl
persist
infect
diseas
kinet
tropism
immunosuppress
lcmv
isol
lcmv
traub
effici
target
antigen
present
cell
dendrit
cell
spleen
perturb
abil
present
antigen
cell
b
cell
result
gener
immunosuppress
host
allow
viral
persist
three
lcmv
strain
bind
high
affin
unlik
nonimmunosuppress
lcmv
variant
armstrong
demonstr
low
affin
lcmv
replic
primarili
splenic
red
pulp
infect
rapidli
resolv
tropism
differ
lcmv
strain
well
signific
infect
dg
es
cell
nonimmunosuppress
lcmv
variant
suggest
altern
current
unidentifi
viral
receptor
util
lcmv
strain
low
affin
lcmv
nearli
genet
ident
except
two
amino
acid
chang
one
occur
viral
polymeras
encod
larg
rna
fragment
posit
lcmv
also
genet
similar
one
amino
acid
differ
posit
genet
phenotyp
comparison
new
world
arenaviru
lcmv
variant
led
observ
amino
acid
play
import
role
abil
util
spiropoul
et
al
gener
leucin
isoleucin
residu
posit
requir
high
affin
bulki
aromat
residu
phenylalanin
tyrosin
gener
result
low
affin
similar
chang
affin
observ
result
serin
phenylalanin
mutat
posit
proper
glycosyl
specif
omannosyl
modif
larg
glycosyltransferas
also
play
import
role
receptor
recognit
lcmv
howev
lcmv
isol
transduc
mous
es
cell
reduc
efficaci
indic
depend
absolut
util
altern
receptor
rule
possibl
among
factor
potenti
limit
util
pseudotyp
vector
low
vector
titer
envelop
instabl
follow
ultracentrifug
glycoprotein
cytotox
limit
tropism
abl
withstand
ultracentrifug
lcmv
glycoprotein
yield
mlv
hiv
vector
titer
similar
wide
use
amphotrop
vsvg
envelop
stabl
cell
line
constitut
express
envelop
gener
demonstr
lcmv
envelop
exhibit
littl
cytotox
comparison
vsvg
envelop
cannon
colleagu
previous
demonstr
success
pseudotyp
mlvbase
retrovir
vector
armstrong
envelop
glycoprotein
gener
mutat
gener
clone
envelop
high
affin
success
use
pseudotyp
investig
receptor
use
affin
among
sever
old
new
world
arenaviru
envelop
vitro
report
show
lcmv
envelop
effici
pseudotyp
nonprim
fiv
lentivir
vector
maintain
entri
properti
seen
wildtyp
arenavirus
furthermor
modifi
lcmv
envelop
mutat
alter
vector
affin
investig
express
liver
preand
postnat
time
point
document
vivo
tissu
tropism
lcmv
pseudotyp
neonat
adult
mice
hypothes
fiv
vector
pseudotyp
lcmv
envelop
glycoprotein
low
bind
affin
would
yield
uniqu
vivo
tissu
tropism
enhanc
gene
transfer
effici
neonat
anim
cell
surfac
glycoprotein
isol
quantif
dystroglycan
express
previous
describ
day
embryo
postnat
mice
collect
time
pregnant
balbc
mice
liver
pool
entir
litter
pool
liver
mg
tissu
per
sampl
homogen
tri
buffer
salin
ph
contain
cocktail
proteas
inhibitor
protein
quantifi
dc
assay
biorad
result
homogen
centrifug
g
minut
suspens
wheat
germ
agglutinin
wga
agaros
bead
ad
pack
bead
per
mg
tissu
incub
end
end
rotat
bead
wash
volum
tri
buffer
salin
ph
bead
elut
boil
minut
laemlli
sd
sampl
buffer
protein
sampl
separ
sdspage
transfer
pvdf
membran
blot
monoclon
antibodi
recogn
glycosyl
form
upstat
polyclon
antibodi
santa
cruz
western
blot
develop
peroxidas
conjug
secondari
antibodi
ecl
detect
pierc
imag
fluorchem
imag
station
alpha
innotech
quikchang
sitedirect
mutagenesi
stratagen
use
creat
point
mutat
lcmv
glycoprotein
plasmid
genbank
access
kind
gift
w
r
beyer
describ
previous
pagepurifi
primer
ggaaaagacaaagtttttcactaggagacttgcaggc
gcctgcaag
tctcctagtgaaaaactttgtcttttcc
use
pcrbase
mutagenesi
gener
leucin
phenylalanin
mutat
residu
lcmv
thu
creat
envelop
construct
lcmv
mutat
confirm
sequenc
secondgener
fiv
vector
use
studi
report
previous
fiv
vector
express
firefli
luciferas
luc
cdna
control
rou
sarcoma
viru
rsv
promot
nuclear
target
ntlacz
direct
cmv
promot
envelop
util
studi
includ
glycoprotein
indiana
strain
vesicular
stomat
viru
vsvg
baculoviru
autographa
californica
lcmv
also
refer
lcmvgp
wehpi
lcmv
pseudotyp
fiv
vector
particl
gener
transient
transfect
plasmid
dna
describ
previous
pseudotyp
virus
express
visual
titer
cell
atcc
follow
limit
dilut
centrifug
concentr
supernat
luciferas
express
vector
titer
quantit
pcr
follow
limit
dilut
cell
rt
activ
describ
lentivir
vector
vivo
experi
resuspend
wv
buffer
cell
atcc
pretreat
carboxyl
ionophor
monensin
sigma
weak
base
ammonium
chlorid
mm
pretreat
appli
hour
prior
vector
transduct
media
chang
fiv
vector
pseudotyp
lcmv
vsvg
mulv
amphotrop
envelop
appli
moi
virus
incub
cell
minut
fresh
media
replac
control
cultur
receiv
vehicl
treatment
four
day
later
gene
transfer
effici
assess
use
galactolight
plu
betagalactosidas
report
gene
assay
system
appli
biosystem
normal
total
protein
lowri
assay
bind
fiv
pseudotyp
adg
isol
skelet
muscl
dilut
concentr
pb
immobil
eiaria
highbond
microtit
plate
sigmaaldrich
follow
immobil
well
wash
time
pb
nonspecif
bind
block
ad
wv
bsapb
incub
hour
wildtyp
lcmv
isol
produc
cell
atcc
precipit
peg
purifi
renografin
gradient
ultracentrifug
resuspend
bsapb
yield
pfuml
fiv
pseudotyp
lcmv
prepar
concentr
state
previous
dilut
transduc
unit
per
millilit
tuml
virus
incub
immobil
hour
orbit
shaker
rpm
follow
wash
wv
pbst
primari
antibodi
detect
bound
lcmv
mab
purifi
igg
bsapb
primari
antibodi
incub
hour
follow
wash
pbst
biotinyl
goat
antimous
igg
secondari
antibodi
wv
bsapb
ad
hour
well
wash
time
pbst
steptavidin
coupl
peroxidas
ad
hour
follow
wash
pbst
detect
use
abt
acid
substrat
allow
optic
densiti
nm
od
record
elisa
reader
block
transduct
lcmv
fiv
pseudotyp
solubl
adg
pfu
wildtyp
lcmv
tu
fivlcmv
pseudotyp
dilut
optimem
vv
fb
indic
amount
purifi
bsa
hour
ice
inoculum
ad
confluent
cultur
cell
atcc
labtek
plate
nunc
incub
minut
co
cell
wash
twice
medium
place
back
co
hour
later
cell
fix
formaldehyd
glutaraldehyd
pb
minut
follow
minut
block
vv
fc
cell
permeabl
vv
wv
saponin
minut
lcmv
infect
detect
use
mab
antilcmvnp
vv
wv
saponin
hour
follow
wash
goat
antimous
igg
fitc
conjug
secondari
antibodi
appli
minut
fluoresc
microscopi
use
object
use
count
np
cell
lcmv
pseudotyp
detect
use
stain
kit
invitrogen
adult
balbc
mice
receiv
follow
dose
vector
via
tail
vein
tu
tu
tu
neonat
balbc
mice
day
life
inject
centrifug
concentr
fiv
vector
via
facial
vein
use
needl
ml
syring
second
vector
deliv
hydrodynam
deliv
dose
vector
vari
depend
titer
concentr
viru
bioluminesc
studi
vector
titer
allow
highest
deliv
dose
tu
follow
tu
tu
tissu
stain
studi
approxim
transduc
unit
deliv
vector
administ
vivo
present
tabl
univers
iowa
institut
anim
care
use
committe
approv
studi
follow
fivluc
deliveri
vivo
luciferas
express
visual
use
bioluminesc
imag
describ
time
point
indic
dluciferin
g
bodi
weight
mgml
pb
xenogen
deliv
intraperiton
anim
use
needl
mice
place
isofluran
anesthesia
five
minut
dluciferin
inject
anim
place
xenogen
imag
cabinet
alameda
ca
imag
use
xenogen
ivi
chargecoupl
devic
ccd
camera
anesthet
imag
data
analyz
signal
intens
quantifi
use
xenogen
live
imag
softwar
three
week
post
transduct
anim
euthan
heart
lung
liver
spleen
kidney
harvest
follow
vascular
perfus
pb
tissu
homogen
tropix
lysi
buffer
appli
biosystem
centrifug
minut
g
luciferas
assay
perform
follow
manufactur
instruct
promega
quantifi
use
pharmingen
monolight
luminomet
sampl
normal
protein
content
lowri
assay
tissu
harvest
anim
week
postinject
embed
tissuetek
oct
compound
frozen
section
made
use
microm
cryostat
hm
slide
fix
minut
vv
glutaraldehydepb
wash
twice
mm
mgcl
pb
minut
slide
xgal
stain
coplin
jar
minut
wash
immedi
mm
mgcl
pb
postfix
occur
vv
glutaraldehyd
vv
formalinpb
minut
slide
counterstain
minut
nuclear
fast
red
coverslip
quantif
express
perform
util
imagepro
plu
media
cybernet
examin
magnif
imag
previous
report
three
imag
per
slide
quantifi
result
averag
least
slide
per
tissu
manual
count
magnif
imag
confirm
accuraci
autom
measur
transduct
effici
cell
type
determin
examin
nuclear
cellular
morpholog
development
express
aand
bdg
liver
tissu
avail
target
receptor
influenc
effici
gene
transfer
neonat
adult
tissu
hypothes
chang
level
viral
receptor
express
newborn
versu
adult
liver
would
influenc
gene
transfer
effici
lcmv
pseudotyp
lentivir
vector
test
hypothesi
isol
wga
enrich
glycoprotein
neonat
liver
compar
express
western
blot
figur
antibodi
recogn
glycosyl
form
bind
high
affin
lcmv
laminin
liver
embryo
earli
postnat
liver
show
high
level
reactiv
adult
liver
reactiv
bare
detect
addit
level
also
high
late
embryon
neonat
liver
compar
adult
anim
interestingli
although
level
remain
high
embryo
level
reactiv
appear
progress
decreas
time
window
could
either
reflect
loss
protein
decreas
glycosyl
effici
overal
effect
loss
function
cell
surfac
other
success
pseudotyp
felin
immunodefici
viru
fiv
base
lentivir
vector
envelop
glycoprotein
baculoviru
rhabdoviru
coronaviru
alphaviru
filoviru
famili
oncoretrovir
hivbas
lentivir
gene
transfer
vector
pseudotyp
lcmv
envelop
yield
titer
similar
vsvg
display
broad
tissu
tropism
util
recombin
lcmv
envelop
lcmv
wehpi
allow
effici
process
cell
surfac
express
achiev
concentr
fiv
titer
tuml
borrow
el
al
previous
demonstr
ph
depend
lcmv
entri
process
use
control
experi
vsv
known
fuse
cell
low
ph
endosom
sought
demonstr
fiv
pseudotyp
virus
retain
wildtyp
entri
characterist
shown
figur
pretreat
cell
either
ionophor
monensin
prevent
endosom
acidif
weak
base
ammonium
chlorid
inhibit
transduct
fiv
vector
pseudotyp
lcmv
find
conclud
envelop
glycoprotein
maintain
nativ
entri
fusion
properti
display
fiv
lentiviru
effect
chang
rout
entri
fiv
normal
take
data
agre
previou
find
sinn
et
al
demonstr
envelop
glycoprotein
retain
nativ
entri
mechan
follow
lentivir
pseudotyp
investig
tropism
lcmv
pseudotyp
vector
knowledg
high
low
affin
arenavirus
display
uniqu
tropism
set
gener
pseudotyp
vector
possess
low
affin
alter
affin
lcmv
mutat
residu
previous
identifi
respons
bind
figur
serin
residu
posit
chang
phenylalanin
mimic
strain
mutat
leucin
posit
mutat
phenylalanin
imit
mutat
lcmv
pseudotyp
yield
low
titer
tuml
wherea
mutat
figur
result
modest
loss
titer
approxim
half
log
tuml
n
compar
parent
tuml
n
pseudotyp
fiv
lcmv
doubl
mutant
contain
mutat
also
result
substanti
loss
vector
titer
unsuit
studi
verifi
alter
affin
perform
seri
competit
assay
viru
bind
affin
determin
immobil
microtit
plate
follow
incub
either
pseudotyp
fiv
wildtyp
lcmv
virus
use
control
equival
viral
load
bound
time
effect
suggest
point
mutat
alter
affin
figur
expect
wildtyp
demonstr
strong
affin
display
littl
affin
figur
bind
measur
optic
densiti
od
approxim
onethird
od
wildtyp
counterpart
demonstr
lcmv
envelop
differ
affin
use
neutral
assay
ask
whether
solubl
inhibit
transduct
prevent
receptor
bind
increas
concentr
solubl
vector
neutral
seen
lcmv
pseudotyp
fiv
figur
wildtyp
lcmv
figur
neutral
observ
wildtyp
lcmv
expect
incub
viru
increas
concentr
bsa
chang
transduct
vector
concentr
solubl
requir
produc
reduct
bind
c
nm
wherea
wildtyp
lcmv
c
nm
find
conclud
mutat
lcmv
strain
envelop
significantli
decreas
affin
context
fiv
lentivir
pseudotyp
determin
vivo
tropism
lcmv
pseudotyp
fiv
vector
deliv
week
old
adult
mice
either
local
respiratori
epithelia
system
via
tail
vein
attempt
transduc
respiratori
tract
adult
mice
yield
undetect
luciferas
signal
enzym
assay
bioluminesc
imag
follow
intranas
intratrach
deliveri
data
shown
intraven
vector
deliveri
adult
mice
also
yield
undetect
level
luciferas
express
figur
contrast
fiv
pseudotyp
baculoviru
envelop
success
transduc
adult
murin
tissu
follow
deliveri
rout
figur
data
shown
shown
previous
lack
transduct
adult
murin
tissu
may
due
development
regul
receptor
strain
lcmv
consequ
posttransl
modif
relat
post
receptor
bind
step
sinc
express
report
abund
fetal
neonat
tissu
figur
next
test
lcmv
tropism
neonat
mice
deliv
fiv
lentivirus
pseudotyp
lcmv
lcmv
envelop
system
via
facial
vein
neonat
balbc
mice
vector
express
firefli
luciferas
report
direct
rsv
promot
express
assess
week
postinject
fiv
pseudotyp
envelop
high
affin
transduc
tissu
less
effici
week
figur
photon
emiss
appear
predominantli
local
liver
occasion
weak
signal
evid
near
inject
site
contrast
anim
transduc
vector
display
significantli
better
express
figur
interestingli
wait
addit
minut
luciferin
administr
enhanc
signal
heart
arrow
figur
arrow
similar
observ
made
week
post
inject
data
shown
week
time
point
follow
ccd
imag
heart
lung
liver
spleen
kidney
harvest
luciferas
assay
perform
assess
tissu
tropism
express
transgen
express
highest
liver
anim
express
detect
spleen
lung
kidney
luciferas
assay
reveal
higher
express
liver
compar
figur
time
higher
express
liver
compar
heart
lcmv
display
heart
transduct
posit
control
pseudotyp
fiv
display
express
liver
heart
neonat
mice
next
receiv
fiv
vector
express
nuclear
target
examin
tissu
cellular
distribut
well
estim
transduct
effici
three
week
postinject
anim
sacrif
tissu
fix
cryosect
xgal
stain
heart
tissu
figur
b
figur
treat
anim
display
figur
neonat
deliveri
transduc
liver
heart
one
week
facial
vein
inject
pseudovirion
mice
imag
util
ccd
camera
repres
photo
mice
week
postinject
depict
follow
inject
wait
addit
minut
ip
deliveri
dluciferin
allow
luciferas
express
detect
heart
arrow
anim
transduc
heart
transduc
anim
display
detect
signal
b
three
week
postinject
heart
lung
liver
spleen
kidney
harvest
luciferas
assay
conduct
express
detect
exclus
liver
tissu
black
bar
pseudovirus
test
heart
gray
bar
pseudovirus
standard
error
plot
denot
statist
signific
p
compar
liver
n
figur
f
addit
transduc
liver
anim
display
uniform
stain
throughout
tissu
figur
variabl
transduct
effici
observ
individu
anim
inject
vector
like
repres
differ
effect
deliv
dose
transduct
effici
rang
posit
cell
liver
section
posit
cell
heart
cardiac
transduct
patchi
predomin
express
observ
cardiomyocyt
morpholog
criteria
hepatocyt
predomin
target
liver
cell
transduct
envelop
glycoprotein
test
tabl
subsequ
cohort
neonat
anim
receiv
three
vector
intraven
luciferas
express
could
monitor
persist
anim
imag
week
postinject
figur
initi
declin
week
express
stabil
remain
rel
constant
throughout
durat
week
experi
shown
figur
start
averag
luciferas
signal
intens
photonsseccm
photonsseccm
se
week
postinject
timepoint
express
week
averag
photonsseccm
photon
seccm
se
express
also
persist
week
timepoint
averag
photonssec
cm
express
control
stabl
photonsseccm
week
time
cours
express
almost
alway
detect
liver
area
earli
time
point
uncommon
detect
signal
near
site
inject
signal
disappear
later
time
point
success
develop
recombin
lcmv
envelop
glycoprotein
alter
affin
known
receptor
use
pseudotyp
fiv
strain
lcmv
addit
member
arenaviru
famili
receptor
independ
typic
display
uniqu
tropism
modifi
envelop
gener
use
knowledg
lcmv
strain
leucin
phenylalanin
substitut
posit
alter
affin
incorpor
mutat
lcmv
glycoprotein
neg
affect
lentiviru
titer
result
alter
receptor
affin
lcmv
envelop
effici
transduc
neonat
murin
hepat
cardiac
tissu
despit
somewhat
titerlimit
lower
deliv
dose
confer
stabl
express
differ
aros
compar
wildtyp
lcmv
lentivir
pseudotyp
respect
bind
affin
neutral
properti
wildtyp
lcmv
bound
approxim
three
time
greater
immobil
pseudotyp
counterpart
figur
multipl
possibl
explan
observ
lcmv
envelop
glycoprotein
normal
form
homotetram
virion
surfac
howev
siv
lentivirus
demonstr
electron
tomographi
possess
trimer
per
virion
thu
glycoprotein
display
surfac
fiv
particl
may
mirror
present
nativ
lcmv
virion
could
reduc
bind
might
also
decreas
recognit
monoclon
antibodi
use
differ
number
glycoprotein
display
virion
may
also
lead
dispar
wildtyp
pseudotyp
receptor
bind
affin
regardless
result
viral
neutral
bind
assay
confirm
bind
significantli
better
vector
lcmv
envelop
lcmv
envelop
transduc
neonat
liver
follow
system
deliveri
express
lentivir
vector
persist
least
month
durat
experi
pseudotyp
poorli
transduc
adult
liver
follow
tail
vein
inject
transduc
liver
adult
neonat
mice
transduct
measur
bioluminesc
slightli
higher
lcmv
pseudotyp
follow
neonat
deliveri
contrast
fail
transduc
adult
mous
tissu
follow
intraven
intranas
intratrach
deliveri
note
lcmv
pseudotyp
transduc
neural
stem
cellsprogenitor
follow
striatal
inject
adult
mous
brain
pseudotyp
fail
transduc
cell
follow
striatal
inject
person
commun
dr
beverli
davidson
differ
transduct
effici
neonat
adult
anim
suggest
arenaviru
receptor
express
vari
consider
develop
inde
studi
express
neonat
vs
adult
liver
tissu
reveal
much
higher
level
express
reactiv
form
alphadystroglycan
perinat
compar
adult
anim
also
detect
signific
gene
transfer
skelet
muscl
even
though
abundantli
express
tissu
glycan
present
react
thought
critic
lcmv
bind
laminin
bind
howev
neonat
liver
lower
molecular
weight
kda
glycoform
typic
found
adult
skelet
muscl
kda
compar
found
brain
dystroglycan
kda
receptor
envelop
bind
high
affin
exhibit
higher
express
late
embryon
neonat
stage
declin
thereaft
interestingli
infect
pattern
develop
brain
lcmv
also
strikingli
depend
age
anim
therefor
although
show
lower
affin
uniqu
glycosyl
pattern
neonat
liver
may
provid
virusglycan
interact
favor
low
affin
arenaviru
bind
may
also
development
regul
cell
type
specif
differ
entri
step
occur
receptor
bind
tropism
vector
may
strongli
affect
competit
viru
ligand
bind
includ
laminin
basement
membran
protein
development
regul
studi
also
need
identifi
potenti
altern
receptor
low
affin
arenavirus
specif
old
world
arenavirus
would
allow
character
express
pattern
receptor
determin
development
regul
contribut
arenaviru
tropism
anoth
possibl
explan
differ
transduct
effici
neonat
adult
mice
may
relat
hepatocellular
prolifer
rate
park
et
al
demonstr
improv
lentivir
transduct
hepatocyt
vivo
follow
cell
cycl
progress
support
hypothesi
came
correl
vector
transduct
effici
brdu
label
mice
differ
age
known
rate
hepatocyt
prolifer
higher
newborn
adult
anim
requir
cell
prolifer
may
also
help
explain
rel
low
effici
lcmv
pseudotyp
vector
tropism
adult
striat
muscl
cell
high
express
lack
nearli
detect
mitot
activ
normal
condit
howev
physiolog
differ
neonat
adult
mice
rule
envelop
confer
higher
transgen
express
neonat
mice
initi
week
postinject
subsequ
display
similar
level
express
remain
week
observ
figur
despit
averag
deliv
vector
dose
approxim
addit
display
uniqu
tropism
includ
cardiomyocyt
transduct
gener
observ
heart
transduct
primarili
locat
ventricular
free
wall
although
rare
transduct
also
observ
interventricular
septum
express
found
outer
myocardium
contrast
display
uniform
transduct
across
full
thick
myocardium
observ
suggest
coronari
circul
rout
deliveri
area
rather
transduct
endocardium
lcmv
pseudotyp
fiv
may
applic
deliveri
gene
hepatocyt
cardiomyocyt
develop
experiment
therapeut
applic
neonat
gene
transfer
sever
posit
advantag
receiv
increas
interest
achiev
util
oncoretrovir
lentivir
vector
hereditari
disord
caus
specif
organ
damag
prenat
neonat
could
treat
earli
irrevers
damag
neonat
immun
system
less
matur
may
allow
enhanc
transduct
facilit
transgen
toler
practic
advantag
neonat
gene
transfer
increas
deliv
vectorbodi
mass
achiev
experiment
perhap
allow
transduct
larger
number
cell
tissu
increas
likelihood
progenitor
cell
target
integr
vector
use
summari
lcmv
pseudotyp
fiv
reduc
affin
receptor
may
applic
neonat
gene
transfer
vector
cardiac
hepat
tissu
via
intraven
deliveri
discuss
text
particip
discuss
pm
design
studi
edit
manuscript
author
read
approv
final
manuscript
